Information Library
Case Studies - Outsourcing
To learn more about a particular aspect of Quintiles’ pharma services, biotech development or drug commercialization services, select a topic at left. If you’ve already specified a choice, you may narrow your search by selecting additional categories in any order. For example, for information on oncology drug development, start by selecting oncology. Then you can narrow your search to Central Lab, News Releases and Europe.
- Sort by: Most Recent
- Title
-
Hepatitis B Vaccine-Successful Study Strategy in Asia
November 9, 2009
Quintiles helped a customer overcome recruitment and regulatory challenges for a Hepatitis B vaccine study in Asia. -
Coordinating Safety Across Functions and Phases
November 3, 2009
A customer faced significant challenges with clinical and post-marketing safety. Without previous drug safety experience, they needed an ally who could provide a full range of safety and risk management solutions. -
Enabling Transformation
September 30, 2009
Biovitrum found an ideal opportunity to transform itself into a fully integrated specialty pharmaceutical company from a biotech discovery and early clinical development company. -
Takeda Hits the Ground Running in New European Territory, with Help from Innovex
September 25, 2009
Our customer was faced with the challenge to launch a countrywide sales team in Spain within 12 weeks. -
Outsourcing and the UK pharmaceutical sector
August 13, 2009
These quotes are from a report called “The role of the CSO in the UK pharmaceutical sector and key decision criteria for their use”, authored by Beth Rogers, Programme Manager and Principal Lecturer in Sales Management, Portsmouth Business School. The report was based on in-depth interviews with senior decisions-makers in the UK pharmaceutical industry. -
A total commercializing solution
August 13, 2009
ProStrakan opts for an entirely new outsourcing model that delivers benefits above and beyond the standard fee for service model. -
Exceeding expectations
August 13, 2009
Discover how the scale of some marketing challenges stretches even the most powerful companies. -
Outsourcing risk and responsibility
August 13, 2009
Astellas, a company who exchanged risk and responsibility in return for greater market share.
Page 1 of 1 (8 items)